BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19487690)

  • 1. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling.
    Pedroja BS; Kang LE; Imas AO; Carmeliet P; Bernstein AM
    J Biol Chem; 2009 Jul; 284(31):20708-17. PubMed ID: 19487690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
    Jin Q; Gao G; Mulder KM
    J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
    Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
    Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation.
    Hoover LL; Burton EG; O'Neill ML; Brooks BA; Sreedharan S; Dawson NA; Kubalak SW
    Biochim Biophys Acta; 2008 Dec; 1783(12):2279-86. PubMed ID: 18773928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses.
    Chen CL; Hou WH; Liu IH; Hsiao G; Huang SS; Huang JS
    J Cell Sci; 2009 Jun; 122(Pt 11):1863-71. PubMed ID: 19461075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt kinase targets association of CBP with SMAD 3 to regulate TGFbeta-induced expression of plasminogen activator inhibitor-1.
    Das F; Ghosh-Choudhury N; Venkatesan B; Li X; Mahimainathan L; Choudhury GG
    J Cell Physiol; 2008 Feb; 214(2):513-27. PubMed ID: 17671970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.
    Samarakoon R; Chitnis SS; Higgins SP; Higgins CE; Krepinsky JC; Higgins PJ
    PLoS One; 2011; 6(7):e22896. PubMed ID: 21829547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
    Anders RA; Doré JJ; Arline SL; Garamszegi N; Leof EB
    J Biol Chem; 1998 Sep; 273(36):23118-25. PubMed ID: 9722540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.
    Schiller HB; Szekeres A; Binder BR; Stockinger H; Leksa V
    Mol Biol Cell; 2009 Feb; 20(3):745-56. PubMed ID: 19037107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity.
    Kortlever RM; Nijwening JH; Bernards R
    J Biol Chem; 2008 Sep; 283(36):24308-13. PubMed ID: 18614541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.
    Denton CP; Zheng B; Evans LA; Shi-wen X; Ong VH; Fisher I; Lazaridis K; Abraham DJ; Black CM; de Crombrugghe B
    J Biol Chem; 2003 Jul; 278(27):25109-19. PubMed ID: 12707256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells.
    Gaedeke J; Noble NA; Border WA
    Kidney Int; 2004 Jul; 66(1):112-20. PubMed ID: 15200418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway.
    Pechkovsky DV; Scaffidi AK; Hackett TL; Ballard J; Shaheen F; Thompson PJ; Thannickal VJ; Knight DA
    J Biol Chem; 2008 May; 283(19):12898-908. PubMed ID: 18353785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
    Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
    J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
    Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
    Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.